Fig. 1From: An update on Peginterferon beta-1a Management in Multiple Sclerosis: results from an interdisciplinary Board of German and Austrian Neurologists and dermatologistsErythema observed in an adult patient injecting peginterferon beta-1a. (Image published with permission from expert. Patient consent was obtained for publication)Back to article page